Evidence map›Paper›PMID 17804789›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci.

John V Raelson, Randall D Little, Andreas Ruether, Hélène Fournier, Bruno Paquin, Paul Van Eerdewegh, W E C Bradley, Pascal Croteau, Quynh Nguyen-Huu, Jonathan Segal and 15 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 4 pooled it
20.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 4 syntheses or guidelines pooled it, 218 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Interleukin-23 receptor genetic polymorphisms and Crohn's disease susceptibility: a meta-analysis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2010
    Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Relationship between theInternational journal of environmental research and public health · 2019
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. New Genetic Approaches to AD: Lessons from APOE-TOMM40 Phylogenetics.Current neurology and neuroscience reports · 2016
    Review
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 4 institutions in 3 countries.

John V RaelsonGenizon BioSciences, Inc., St. Laurent, QC, Canada H4T 2C7. john.raelson@genizon.com
Randall D Little
Andreas Ruether
Hélène Fournier
Bruno Paquin
Paul Van Eerdewegh
W E C Bradley
Pascal Croteau
Quynh Nguyen-Huu
Jonathan Segal
Sophie Debrus
René Allard
Philip Rosenstiel
Andre Franke
Gunnar Jacobs
Susanna Nikolaus
Jean-Michel Vidal
Peter Szego
Nathalie Laplante
Hilary F Clark
René J Paulussen
John W Hooper
Tim P Keith
Abdelmajid Belouchi
Stefan Schreiber
Institute for Medical Biology · PLKiel University · DEMcGill University · CAUniversité de Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome-wide association (GWA) studies offer a powerful unbiased method for the identification of multiple susceptibility genes for complex diseases. Here we report the results of a GWA study for Crohn's disease (CD) using family trios from the Quebec Founder Population (QFP). Haplotype-based association analyses identified multiple regions associated with the disease that met the criteria for genome-wide significance, with many containing a gene whose function appears relevant to CD. A proportion of these were replicated in two independent German Caucasian samples, including the established CD loci NOD2 and IBD5. The recently described IL23R locus was also identified and replicated. For this region, multiple individuals with all major haplotypes in the QFP were sequenced and extensive fine mapping performed to identify risk and protective alleles. Several additional loci, including a region on 3p21 containing several plausible candidate genes, a region near JAKMIP1 on 4p16.1, and two larger regions on chromosome 17 were replicated. Together with previously published loci, the spectrum of CD genes identified to date involves biochemical networks that affect epithelial defense mechanisms, innate and adaptive immune response, and the repair or remodeling of tissue.

Indexed as

Founder EffectGenetic Predisposition to DiseaseGenome, HumanAllelesChromosomes, Human, Pair 17Chromosomes, Human, Pair 3Chromosomes, Human, Pair 4Crohn DiseaseFranceGenetic MarkersGenetics, PopulationHaplotypesHumansNod2 Signaling Adaptor ProteinPhysical Chromosome MappingQuebecGenetic MarkersIL23R protein, humanNOD2 protein, humanNod2 Signaling Adaptor ProteinReceptors, Interleukin

Identifiers

PMID17804789
PMCPMC1965486
OpenAlexW2149585871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.